Validity and reliability of the us national cancer institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) Academic Article uri icon

Overview

MeSH Major

  • Adverse Drug Reaction Reporting Systems
  • Antineoplastic Agents
  • Chemoradiotherapy
  • Drug-Related Side Effects and Adverse Reactions
  • National Cancer Institute (U.S.)
  • Neoplasms
  • Radiation Injuries
  • Surveys and Questionnaires
  • Terminology as Topic

abstract

  • Evidence demonstrates favorable validity, reliability, and responsiveness of PRO-CTCAE in a large, heterogeneous US sample of patients undergoing cancer treatment. Studies evaluating other measurement properties of PRO-CTCAE are under way to inform further development of PRO-CTCAE and its inclusion in cancer trials.

publication date

  • November 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4857599

Digital Object Identifier (DOI)

  • 10.1001/jamaoncol.2015.2639

PubMed ID

  • 26270597

Additional Document Info

start page

  • 1051

end page

  • 9

volume

  • 1

number

  • 8